Posted: November 7, 2017
Leverages the strength of Nelson Labs, Nordion and Sterigenics to deliver on its mission of Safeguarding Global Health™
Posted: October 31, 2017
Acquisition creates the leading global extractables and leachables lab testing platform to serve the pharmaceutical and medical device industries CLEVELAND, OH. – Oct.
Posted: January 24, 2017
SALT LAKE CITY, UT – January 25, 2017 – Nelson Laboratories, a leading provider of testing services for Medical Device, Pharmaceutical, Tissue and life science companies today announced the launch of a new, redesigned version of its website, nelsonlabs.com. Highlights of the updated site include a cleaner and more attractive design, a more engaging user experience with enhanced search and navigation features, and clearer calls to action for new and existing clients exploring the site.
Posted: May 17, 2016
Nelson Laboratories and Healthmark have Joined Forces to Offer a Surveillance Tool for Testing of Duoendoscopes
SALT LAKE CITY, UT AND FRASER, MI – May 17, 2016 – Nelson Laboratories and Healthmark Industries today announced the introduction of an Endoscope Sampling Kit for the random testing of duodenoscopes in compliance with CDC guidelines. Endoscope manufacturers, regulatory bodies and healthcare facilities are increasingly concerned about the spread of communicable diseases, including clinically relevant microorganisms, on reprocessed medical devices. Healthmark Industries and Nelson Laboratories have joined forces to create an endoscope sampling kit for the purpose of monitoring and reporting objective results from clinical scopes.
Posted: April 4, 2016
DEERFIELD, IL AND SALT LAKE CITY, UT -- APRIL 4, 2016 – Sterigenics International LLC, the leading global provider of contract sterilization, gamma technologies and medical isotopes, and a portfolio company of Warburg Pincus and GTCR, today announced that it has acquired Nelson Laboratories, Inc., the largest U.S. provider of life-cycle microbiology testing services for the medical devices, pharmaceutical and tissue industries. Terms of the transaction were not disclosed.